← back to search

Lina Song

Hubei University of Medicine · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Glycosylation and Glycoproteins Research, DNA and Nucleic Acid Chemistry, Circular RNAs in diseases, and MicroRNA in disease regulation.
h-index
29
citations
3,979
works
129
NIH funding
primary concept
email

Recent publications

Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma
Advanced Science 2025cited by 28position: middledoi
GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation
Cellular Oncology 2024cited by 8position: middledoi
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma
Cellular and Molecular Gastroenterology and Hepatology 2022cited by 51position: middledoi
Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway
Aging 2021cited by 19position: middledoi
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation
Journal of Clinical Investigation 2019cited by 43position: middledoi
Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer
Cancer Discovery 2019cited by 29position: middledoi
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Cancer Cell 2018cited by 155position: middledoi
Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice
Journal of Cancer Research and Therapeutics 2018cited by 7position: middledoi
Bevacizumab followed by chemotherapy is potential therapy for gastric cancer.
PubMed 2017cited by 5position: middle
Biogenesis and function of tRNA fragments during sperm maturation and fertilization in mammals
Science 2015cited by 1,314position: middledoi
Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation
Journal of Biological Chemistry 2015cited by 27position: middledoi
Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice
Protein & Cell 2014cited by 63position: middledoi
Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen
Journal of Biological Chemistry 2012cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhi Dai · Fudan University3 papers (2022–2025)Yalei Lv · Hebei Medical University3 papers (2017–2021)Jialiang Cai · Fudan University3 papers (2022–2025)Shiping Chen · BGI Group (China)2 papers (2024–2025)Zheng‐Jun Zhou · Sun Yat-sen University2 papers (2022–2024)Junwei Zeng · Zunyi Medical University2 papers (2012–2015)Rongjuan Mi · Henry Ford Health System2 papers (2012–2015)Jing-Lei Wan · Fudan University2 papers (2022–2024)Arlene B. Chapman · Deakin University2 papers (2012–2015)Richard D. Cummings · Beth Israel Deaconess Medical Center2 papers (2012–2015)Jun-Xian Du · Sun Yat-sen University2 papers (2022–2025) · 2 papers (2012–2015)Tongzhong Ju · Center for Drug Evaluation and Research2 papers (2012–2015)Liang Chang · Hebei University of Chinese Medicine2 papers (2017–2018)Wei Liu · Hebei Medical University2 papers (2017–2018)Yingchun Wang · Inner Mongolia Agricultural University2 papers (2012–2015)Jian Zhou · Wuhan Third Hospital1 papers (2025–2025)Jia Fan · Ministry of Education of the People's Republic of China1 papers (2025–2025)Jianmei Wang · Harbin Medical University1 papers (2012–2012)Shuangshuang Dong · Fudan University1 papers (2022–2022)